Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 09-2012 | 09-2011 | 09-2010 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,627 | 21,399 | 23,310 | 7,904 | N/A |
| Depreciation Amortization | 1,483 | 762 | 816 | 553 | N/A |
| Accounts receivable | 241 | -788 | -251 | -6 | N/A |
| Accounts payable and accrued liabilities | 115 | 763 | 58 | 181 | N/A |
| Other Working Capital | 741 | 93 | -2,400 | -18,411 | N/A |
| Other Operating Activity | -1,554 | 394 | 2,486 | -396 | 0 |
| Operating Cash Flow | $10,653 | $22,623 | $24,019 | $-10,175 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -606 | -186 | -436 | -37 | N/A |
| Purchase Of Investment | -115,888 | -47,694 | -33,574 | -603 | N/A |
| Sale Of Investment | 47,278 | 28,700 | 16,764 | 2,303 | N/A |
| Other Investing Activity | 0 | 1,140 | -436 | 0 | 0 |
| Investing Cash Flow | $-69,216 | $-18,040 | $-17,682 | $1,663 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,000 | N/A | N/A |
| Debt Repayment | N/A | N/A | -2,000 | -7 | N/A |
| Common Stock Issued | 60,451 | -909 | 34 | 15 | N/A |
| Common Stock Repurchased | -3,540 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $56,911 | $-909 | $34 | $8 | $N/A |
| Beginning Cash Position | 10,511 | 6,837 | 466 | 8,970 | N/A |
| End Cash Position | 8,859 | 10,511 | 6,837 | 466 | N/A |
| Net Cash Flow | $-1,652 | $3,674 | $6,371 | $-8,504 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,653 | 22,623 | 24,019 | -10,175 | N/A |
| Capital Expenditure | -606 | -252 | -445 | -37 | N/A |
| Free Cash Flow | 10,047 | 22,371 | 23,574 | -10,212 | 0 |